<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Doxorubicin, a chemotherapeutic agent for treatment of patient with breast cancer, was used as a positive control and exhibited an approximately twentyfold higher toxicity with an IC
 <sub class="sub">50</sub> = 0.41 µg/mL ± 0.03 µg/mL. However, severe adverse effects of doxorubicin have been reported, such as cardio- and nephrotoxicities [
 <xref rid="B31-molecules-24-02153" ref-type="bibr" class="xref">31</xref>,
 <xref rid="B32-molecules-24-02153" ref-type="bibr" class="xref">32</xref>]. In contrast, for preparations from frankincense only minimal adverse events like heartburn or nausea have been reported [
 <xref rid="B33-molecules-24-02153" ref-type="bibr" class="xref">33</xref>].
</p>
